rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1996-4-1
|
pubmed:abstractText |
Some patients with inflammatory bowel disease have anemia that is refractory to treatment with iron and vitamins. We examined whether administering iron and recombinant erythropoietin could raise hemoglobin levels in such patients.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
334
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-23
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8592524-Adolescent,
pubmed-meshheading:8592524-Adult,
pubmed-meshheading:8592524-Anemia,
pubmed-meshheading:8592524-Colitis, Ulcerative,
pubmed-meshheading:8592524-Crohn Disease,
pubmed-meshheading:8592524-Double-Blind Method,
pubmed-meshheading:8592524-Drug Resistance,
pubmed-meshheading:8592524-Erythropoietin,
pubmed-meshheading:8592524-Female,
pubmed-meshheading:8592524-Hematocrit,
pubmed-meshheading:8592524-Humans,
pubmed-meshheading:8592524-Interleukin-1,
pubmed-meshheading:8592524-Iron,
pubmed-meshheading:8592524-Linear Models,
pubmed-meshheading:8592524-Male,
pubmed-meshheading:8592524-Middle Aged,
pubmed-meshheading:8592524-Monocytes,
pubmed-meshheading:8592524-Prospective Studies,
pubmed-meshheading:8592524-Recombinant Proteins,
pubmed-meshheading:8592524-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
|
pubmed:affiliation |
Department of Medicine, University of Hamburg, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|